CADMUS, Protokoll Nr. CNTO1275-PSO-3006
Laufzeit: 01.01.2011 - 31.12.2013
Kurzfassung
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Ustekinumab in the Treatment of Adolescent Subjects With Moderate to Severe Plaque-type Psoriasis (CADMUS)
